BAKER BROS ADVISORS LLC Insider Trading
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is a 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a Director in INCYTE CORP ($INCY) and a Director in ALEXION PHARMACEUTICALS INC ($ALXN) and a 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and a Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and a in XOMA Corp ($XOMA) and a Director in ACADIA PHARMACEUTICALS INC ($ACAD) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in GENOMIC HEALTH INC ($GHDX) and a 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and a 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and a Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and a Director in Zymeworks Inc. ($ZYME) and a Director in Kodiak Sciences Inc. ($KOD) and a 10% Owner in Invitae Corp ($NVTA) and a Director in IGM Biosciences, Inc. ($IGMS) and a 10% Owner in Atreca, Inc. ($BCEL) and a in Mirati Therapeutics, Inc. ($MYG) and a 10% Owner in Mirati Therapeutics, Inc. ($MYG) and a Director in Talis Biomedical Corp ($TLIS) and a Director in Aeglea BioTherapeutics, Inc. ($AGLE) and a in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and a in Intellia Therapeutics, Inc. ($NTLA) and a Director in BeiGene, Ltd. ($BGNE) and a Director in Prelude Therapeutics Inc ($PRLD) and a Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and a in HOOKIPA Pharma Inc. ($HOOK).
Address: 667 MADISON AVENUE 21ST FLOOR NEW YORK US 10065 NY
Companies in which BAKER BROS ADVISORS LLC is an Insider
ACADIA PHARMACEUTICALS INC
Trading Symbol: ACADIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 3,476,727 shares
Current Value: $132,776,204
Latest Transaction: Jun 25 2020
$ACAD Market Capitalization: $4.67B
$ACAD Previous Close: $38.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aeglea BioTherapeutics, Inc.
Trading Symbol: AGLEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 25 2021
$AGLE Market Capitalization: $56.54M
$AGLE Previous Close: $4.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALEXION PHARMACEUTICALS, INC.
Trading Symbol: ALXNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 997,764 shares
Current Value: $127,434,418
Latest Transaction: May 18 2020
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Atreca, Inc.
Trading Symbol: BCELIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 309,730 shares
Latest Transaction: Jul 20 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BeiGene, Ltd.
Trading Symbol: BGNEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 10,418 shares
Current Value: $374,215
Latest Transaction: Dec 04 2020
$BGNE Market Capitalization: $1.14B
$BGNE Previous Close: $35.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BELLICUM PHARMACEUTICALS, INC
Trading Symbol: BLCMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 412,246 shares
Current Value: $5,181,932
Latest Transaction: Jan 19 2018
$BLCM Market Capitalization: $335.83M
$BLCM Previous Close: $12.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOCRYST PHARMACEUTICALS INC
Trading Symbol: BCRXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 1,656,688 shares
Current Value: $9,393,421
Latest Transaction: Aug 16 2016
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENOMIC HEALTH INC
Trading Symbol: GHDXIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 165,980 shares
Current Value: $4,562,790
Latest Transaction: Oct 03 2019
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HOOKIPA Pharma Inc.
Trading Symbol: HOOKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC:
Holdings: 72,128 shares
Latest Transaction: Apr 23 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IDERA PHARMACEUTICALS, INC.
Trading Symbol: IDRAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: 10% Owner, Director
Holdings: 350,721 shares
Current Value: $547,125
Latest Transaction: Jul 03 2019
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IGM Biosciences, Inc.
Trading Symbol: IGMSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 267,065 shares
Latest Transaction: Feb 23 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INCYTE CORP
Trading Symbol: INCYIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 2,850,042 shares
Current Value: $336,817,964
Latest Transaction: Oct 02 2020
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Intellia Therapeutics, Inc.
Trading Symbol: NTLAIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of BAKER BROS ADVISORS LLC:
Holdings: 976,214 shares
Current Value: $12,983,646
Latest Transaction: May 11 2016
$NTLA Market Capitalization: $471.17M
$NTLA Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Invitae Corp
Trading Symbol: NVTAIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 845,858 shares
Current Value: $7,443,550
Latest Transaction: Mar 29 2018
$NVTA Market Capitalization: $281.95M
$NVTA Previous Close: $8.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kiniksa Pharmaceuticals, Ltd.
Trading Symbol: KNSAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 98,980 shares
Latest Transaction: Jul 28 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kodiak Sciences Inc.
Trading Symbol: KODIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 1,024,982 shares
Latest Transaction: Sep 25 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Mirati Therapeutics, Inc.
Trading Symbol: MYGIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC:
Holdings: 141,244 shares
Latest Transaction: Nov 20 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Neoleukin Therapeutics, Inc.
Trading Symbol: NLTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director, 10% Owner
Holdings: 320,049 shares
Current Value: $6,020,122
Latest Transaction: May 13 2021
$NLTX Market Capitalization: $451.60M
$NLTX Previous Close: $18.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Prelude Therapeutics Inc
Trading Symbol: PRLDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 876,061 shares
Latest Transaction: Jan 29 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RHYTHM PHARMACEUTICALS, INC.
Trading Symbol: RYTMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC:
Holdings: 82,969 shares
Latest Transaction: Oct 06 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Trading Symbol: SGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 4,082,851 shares
Current Value: $248,196,512
Latest Transaction: May 19 2020
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Talis Biomedical Corp
Trading Symbol: TLISIndustry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 571,659 shares
Latest Transaction: Feb 19 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
XOMA Corp
Trading Symbol: XOMAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC:
Holdings: 90,538 shares
Current Value: $381,165
Latest Transaction: Jul 23 2015
$XOMA Market Capitalization: $25.10M
$XOMA Previous Close: $4.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Zymeworks Inc.
Trading Symbol: ZYMEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 0 shares
Latest Transaction: May 12 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC
Sentiment: All, ACAD, AGLE, ALXN, BCEL, BGNE, BLCM, BCRX, GHDX, HOOK, IDRA, IGMS, INCY, NTLA, NVTA, KNSA, KOD, MYG, NLTX, PRLD, RYTM, SGEN, TLIS, XOMA, ZYME
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | NLTX | Neoleukin Therapeu ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 11.40 | 25,000 | 285,000 | 25,000 | |
Feb 25 2021 | AGLE | Aeglea BioTherapeu ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 7.11 | 47,200 | 335,592 | 47,200 | |
Feb 23 2021 | IGMS | IGM Biosciences, I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 91.50 | 6,423 | 587,705 | 6,423 | |
Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 6,427,576 | 0 | 27,511,741 | |
Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 536,438 | 0 | 2,345,481 | |
Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 7,286,794 | 0 | 21,084,165 | |
Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 536,414 | 0 | 1,809,043 |